Abstract
The widely accepted notion that capital markets are significantly influenced by macroeconomic factors underscores the importance of examining how these factors directly and indirectly affect stock valuations. Stock prices are inherently volatile, subject to the whims of the market, yet they are expected to converge with the intrinsic value of the shares they represent. Uncovering this fair value is essential for strategic investment decisions. This review article aims to provide an in-depth analysis of the impact of macroeconomic variables on the financial performance of specific companies, using macroeconomic data to elucidate the shifts in the fair value of their shares. By focusing on Baiyunshan, a leading pharmaceutical company in China, the article illustrates the tangible effects of macroeconomic factors on stock valuation. It offers a comprehensive exploration of various evaluation models, providing investors with a robust framework to assess the intrinsic value of publicly traded pharmaceutical companies. This study not only bridges the gap in current understanding but also equips investors with the necessary tools to navigate the complexities of the capital market with greater confidence and precision.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call